Organoid Kit Market Report 2026

Organoid Kit Market Overview

• Organoid Kit market size has reached to $1.31 billion in 2025 • Expected to grow to $2.75 billion in 2030 at a compound annual growth rate (CAGR) of 15.9% • Growth Driver: Surge In Infectious Diseases Fueling The Growth Of The Market Due To Rising Pathogen Transmission And Research Demand • Market Trend: Innovative Solutions Enhance Consistency And Scalability In Organoid Studies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Organoid Kit Market?

Organoid kit refers to a specialized laboratory toolset designed to culture and grow miniaturized, three-dimensional organ-such as structures from stem cells. These kits provide the essential reagents, growth factors, and protocols needed to replicate organ development and function in vitro. They are widely used in biomedical research, drug discovery, and disease modeling. The main types of the organoid kit market are brain organoids, kidney organoids, intestinal organoids, liver organoids, and others. Brain organoids refer to three-dimensional, miniaturized models of the human brain developed for research and therapeutic applications. There are technologies such as 3D cell culture technology, microfluidics technology, bioprinting technology, and electrospinning technology. The source types include human-derived organoids, animal-derived organoids, and cell line-derived organoids. These are used for various application areas such as drug discovery and development, disease modeling, personalized medicine, regenerative medicine, and others. These are also used by various end-users such as research institutes, pharmaceutical companies, contract research organizations, and biotech companies.

What Is The Organoid Kit Market Growth Forecast?

The organoid kit market size is expected to see rapid growth in the next few years. It will grow to $2.75 billion in 2030 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to expansion in personalized medicine, integration of ai in organoid analysis, improvements in microfluidics platforms, growth of regenerative medicine applications, increased collaborations between pharma and biotech companies. Major trends in the forecast period include 3D cell culture advancements, personalized organoid development, microfluidics-based organoid platforms, organoid bioprinting technology, stem cell-derived disease modeling.

Global Organoid Kit Market Segmentation

1) By Type: Brain Organoids, Kidney Organoids, Intestinal Organoids, Liver Organoids, Other Organoid Types 2) By Technology: 3D Cell Culture Technology, Microfluidics Technology 3) By Source: Human-Derived Organoids, Animal-Derived Organoids, Cell Line-Derived Organoids 4) By Application: Drug Discovery and Development, Disease Modeling, Personalized Medicine, Other Applications 5) By End-User: Research Institutes, Pharmaceutical Companies, Contract Research Organizations, Biotech Companies Subsegments: 1) By Brain Organoids: Cerebral Organoids, Midbrain Organoids, Retinal Organoids 2) By Kidney Organoids: Nephron Organoids, Collecting Duct Organoids, Glomerular Organoids 3) By Intestinal Organoids: Small Intestine Organoids, Colon Organoids, Gastric Organoids 4) By Liver Organoids: Hepatic Organoids, Cholangiocyte Organoids, Biliary Organoids 5) By Other Organoid Types: Pancreatic Organoids, Lung Organoids, Heart Organoids, Tumor Organoids

What Is The Driver Of The Organoid Kit Market?

The increasing incidence of infectious diseases is expected to propel the growth of the organoid kit market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, that can spread directly or indirectly from one person to another. The rise in infectious diseases is due to poor sanitation and overcrowding, resulting to easier transmission of pathogens and higher infection rates. Organoid kits help to eradicate infectious diseases by enabling researchers to model human tissues in the lab, allowing precise study of pathogen behavior, infection mechanisms, and testing of potential treatments. For instance, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the increasing incidence of infectious diseases is driving the growth of the organoid kit industry.

Key Players In The Global Organoid Kit Market

Major companies operating in the organoid kit market are STEMCELL Technologies Inc., Bio-Techne Corporation, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., MIMETAS B.V., Emulate Inc., CN Bio Innovations Limited, InSCREENeX GmbH, TheWell Bioscience Inc., Prellis Biologics Inc., Crown Bioscience International, AMS Biotechnology (Europe) Limited (AMSBIO), Xylyx Bio Inc., Organovo Holdings Inc., HUB Organoids Holding B.V., Cellesce Ltd., DefiniGEN Ltd., OcellO B.V., AlveoliX AG, VitroLabs Inc.

Global Organoid Kit Market Trends and Insights

Major companies operating in the organoid kit market are focusing on developing rapid aggregate formations, to accelerate organoid development timelines, improve reproducibility, and enable high-throughput applications for drug discovery, disease modeling, and personalized medicine. Rapid aggregate formation refers to the ability to quickly generate thousands of uniform pluripotent stem cell aggregates in a single day, significantly reducing organoid development time. For instance, in June 2025, Pluristyx Inc., a US-based biotechnology company, launched its PluriForm Organoid Kit, designed to simplify the creation of pluripotent stem cell aggregates and speed up organoid development. The kit offers a ready-to-use platform that shortens the timeline for generating mature organoids from months to just weeks. This integrates optimized growth media and standardized protocols, that ensures reproducible results across various cell types. It also supports high-throughput applications, making it suitable for large-scale disease modeling and drug screening.

What Are Latest Mergers And Acquisitions In The Organoid Kit Market?

In April 2024, Sartorius AG, a Germany-based biotechnology company, partnered with TheWell Bioscience Inc. to create robust and versatile tools for cellular modeling. Through this partnership, Sartorius AG aims to expand its advanced 3D cell culture solutions by integrating TheWell Bioscience Inc.’s specialized hydrogel platforms, thereby strengthening its position in organoid and spheroid research tools. TheWell Bioscience Inc. is a US-based biotechnology company that specializes in 3D cell culture and organoid technology using advanced hydrogel platforms.

Regional Outlook

North America was the largest region in the organoid kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Organoid Kit Market?

The organoid kit market consists of revenues earned by entities by providing services such as organoid co-culture kits, organoid-on-a-chip integration services, and organoid toxicology testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The organoid kit market also includes sales of organoid biobanking kits, organoid functional assay kits, and organoid gene editing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.